2014 China pharmaceutical brand value ranking released

Source: Xinkangjie on the evening of August 14, 2014, the 2014 China pharmaceutical brand value ranking was officially released in Boao, Hainan Province The first place was the brand value of 7.619 billion yuan of Sanofi The second and third places were novoline and Yunnan Baiyao with 6.72 billion yuan and 6.239 billion yuan respectively Is China's pharmaceutical brand value ranking based on healthy China? A study on the brand value of the brands on the list of Chinese pharmaceutical brands This year, there are 14 new brands in the brand value ranking, with the top 50 brands worth 96.694 billion yuan in total, and several national brands, such as Yunnan Baiyao and dong'a-jiao, worth more than 5 billion yuan Highlight 1 of the list: in this year's list of Chinese drug brand values with high brand value of chronic disease drugs, the ranking of chronic disease drug brands is relatively high, among which 6 of the top 10 belong to chronic disease drugs Especially this year's first and second place Plavix and novoline are chronic disease drugs Highlight 2: the number of brands with more than 1 billion yuan has increased This year, the number of brands with more than 1 billion yuan has increased by 11, to 28, compared with last year Among them, the brand value of ethnic medicine has increased significantly, with 10 ethnic medicine brands worth more than 1 billion yuan (only 4 last year) Highlight 3: foreign brands have increased, but the value of old OTC foreign brands has declined Of the 50 brands listed in this year's list, 22 are foreign brands, an increase of 6 over last year Although the number has increased, the value of some old OTC foreign brands is declining For example, compared with 2013, the value of fenbide brand has dropped 250 million yuan, ranking 7 places down This is related to the life cycle of OTC products, the reduction of brand investment and advertising Highlight 4: the value of local brands is rising fast The average value of 22 foreign brands on the list this year is about 2.53 billion yuan, 28.6% higher than that of last year's foreign brands The average value of 28 local brands is about 1.47 billion yuan, 76.6% higher than that of last year's local brands This is related to the rise of Chinese local brands More and more local enterprises attach importance to the construction of their own product brands The evaluation of China's drug brand value ranking shows that the evaluation goal is to measure the future benefits brought by the calculated brand to the brand owner purely from the perspective of brand value; analyze the general situation and development trend of the current Chinese drug market value through the value trend; excavate the core elements affecting the drug brand value, and provide research basis for the creation of China's drug brand value 76 brands on the 2013 Chinese drug brand list are selected as the calculation samples; the calculation value range is the single or series products of the same brand name in the same treatment field; the calculation value range is the Chinese market Theoretical system m-dbv (method of drug brand value) drug brand calculation method: V drug brand value = V future revenue + V brand residual value; V future revenue: the revenue that the calculated brand will bring to the brand owner in the next three years, and the core influencing factor is the brand base of 4d-bes evaluation system V brand residual value: the calculated brand 10 Brand benchmark of brand residual value after: calculate the brand loyalty, brand reputation and brand loyalty of a single brand through U & a survey of consumers, and form a quantitative total calculation year: the last year of the list Ranking method: by calculating all brand values of the brands on the list of Chinese drug brands in the current year, ranking is based on the value level, and the final list is formed for the top 50 brands (the data of sample brands mainly comes from the third party mysterious person research, consumer research, and its public data)